Determinants of cervical cancer screening in Southeast Asia: A systematic review using the COM-B model and the theoretical domains framework.
OpenAlex 토픽 ·
Cervical Cancer and HPV Research
Global Cancer Incidence and Screening
Reproductive tract infections research
[OBJECTIVE] To identify the determinants of cervical cancer screening (CCS) uptake in Southeast Asia (SEA), using the COM-B model and the Theoretical Domains Framework (TDF).
- 표본수 (n) 20
APA
Jia Hui Lim, Li Ling Yeap, et al. (2026). Determinants of cervical cancer screening in Southeast Asia: A systematic review using the COM-B model and the theoretical domains framework.. Preventive medicine, 207, 108564. https://doi.org/10.1016/j.ypmed.2026.108564
MLA
Jia Hui Lim, et al.. "Determinants of cervical cancer screening in Southeast Asia: A systematic review using the COM-B model and the theoretical domains framework.." Preventive medicine, vol. 207, 2026, pp. 108564.
PMID
41887293
Abstract
[OBJECTIVE] To identify the determinants of cervical cancer screening (CCS) uptake in Southeast Asia (SEA), using the COM-B model and the Theoretical Domains Framework (TDF).
[METHODS] A comprehensive search was conducted in PubMed/Medline, Scopus, Web of Science, CINAHL, Embase, ProQuest and PsycINFO. Primary qualitative and quantitative studies published in English from January 2015 to October 2025 that reported determinants of CCS uptake in SEA were included. The Joanna Briggs Institute critical appraisal tool was used to conduct the quality assessment of the studies.
[RESULTS] A total of 72 articles were included, with most studies from Malaysia (n = 20) and using the Pap smear screening method (n = 39). The review mapped 230 items onto COM-B and the TDF as either barriers or facilitators, with every TDF domain appearing in at least one study. The most reported domains were 'knowledge' (60/72 studies) and 'environmental context and resources' (52/72 studies), with 'social influence' also frequently identified (35/72 studies).
[CONCLUSIONS] The findings highlight that CCS uptake in SEA is shaped not only by knowledge but also by opportunity-related factors and motivational factors. Interventions could therefore combine education with measures to address access and emotional barriers, in addition to leveraging provider and community support.
[METHODS] A comprehensive search was conducted in PubMed/Medline, Scopus, Web of Science, CINAHL, Embase, ProQuest and PsycINFO. Primary qualitative and quantitative studies published in English from January 2015 to October 2025 that reported determinants of CCS uptake in SEA were included. The Joanna Briggs Institute critical appraisal tool was used to conduct the quality assessment of the studies.
[RESULTS] A total of 72 articles were included, with most studies from Malaysia (n = 20) and using the Pap smear screening method (n = 39). The review mapped 230 items onto COM-B and the TDF as either barriers or facilitators, with every TDF domain appearing in at least one study. The most reported domains were 'knowledge' (60/72 studies) and 'environmental context and resources' (52/72 studies), with 'social influence' also frequently identified (35/72 studies).
[CONCLUSIONS] The findings highlight that CCS uptake in SEA is shaped not only by knowledge but also by opportunity-related factors and motivational factors. Interventions could therefore combine education with measures to address access and emotional barriers, in addition to leveraging provider and community support.
MeSH Terms
Humans; Uterine Cervical Neoplasms; Female; Early Detection of Cancer; Asia, Southeastern; Papanicolaou Test; Health Knowledge, Attitudes, Practice; Mass Screening; Vaginal Smears
같은 제1저자의 인용 많은 논문 (5)
- Efficacy and Safety of Intratympanic Botulinum Toxin Injection on Middle Ear Myoclonic Tinnitus.
- DEL-1 is an Endogenous Senolytic Protein that Inhibits Senescence-Associated Bone Loss.
- Smoking, Alcohol, and Abdominal Obesity Increase Gastric Cancer Risk after Helicobacter pylori Eradication.
- Immunotherapy in uncommon EGFR-mutant NSCLC: Revisiting a therapeutic gray zone.
- Personalized pharmacokinetic-pharmacodynamic guided therapy via an induced pluripotent stem cell-derived multi-organoid platform in NF1-mutant breast cancer.